Pentoxifylline as adjunctive therapy in leg ulcer management

Area of Science:

• Vascular Biology
• Dermatology
• Pharmacology

Background:

• Refractory leg ulcers often result from impaired venous or arterial microcirculation.
• A proposed mechanism involves narrowed capillaries, increased permeability, and fibrin sheath deposition, hindering oxygen and nutrient delivery.

Observation:

• Activated white blood cells and inadequate fibrinolysis contribute to capillary dysfunction.
• Perivascular fibrin sheath formation impedes essential nutrient and oxygen transport to tissues.

Findings:

• Pentoxifylline, combined with standard care, significantly improved healing in refractory leg ulcers.
• The drug reverses abnormal white blood cell, red blood cell, and platelet function.
• Pentoxifylline reduces blood viscosity and vascular permeability, addressing key ulcer development mechanisms.

Implications:

• Therapeutic strategies should focus on reversing microcirculatory deficits for effective leg ulcer healing.
• Pentoxifylline shows promise as an adjunct therapy for challenging leg ulcer cases.
• Understanding pentoxifylline's mechanisms offers insights into leg ulcer pathogenesis and treatment.